Bittoo Kanwar - Jul 7, 2021 Form 4 Insider Report for Applied Molecular Transport Inc. (AMTI)

Signature
/s/ Brandon Hants Attorney-in-Fact for Bittoo Kanwar
Stock symbol
AMTI
Transactions as of
Jul 7, 2021
Transactions value $
-$297,843
Form type
4
Date filed
7/8/2021, 07:49 PM
Next filing
Dec 23, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMTI Common Stock Options Exercise $17.9K +7.5K $2.38* 7.5K Jul 7, 2021 Direct
transaction AMTI Common Stock Sale -$279K -6.65K -88.68% $42.01* 849 Jul 7, 2021 Direct F1, F2
transaction AMTI Common Stock Sale -$34.1K -800 -94.23% $42.67* 49 Jul 7, 2021 Direct F1, F3
transaction AMTI Common Stock Sale -$2.15K -49 -100% $43.84* 0 Jul 7, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMTI Stock Option (Right to Buy) Options Exercise $0 -7.5K -5.24% $0.00 136K Jul 7, 2021 Common Stock 7.5K $2.38 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on January 28, 2021.
F2 The price reported in column is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.53 to $42.51, inclusive. The reporting person undertakes to provide Applied Molecular Transport, Inc., any security holder of Applied Molecular Transport, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in column is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.58 to $42.73, inclusive. The reporting person undertakes to provide Applied Molecular Transport, Inc., any security holder of Applied Molecular Transport, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 1/4th of the shares subject to the option became vested and exercisable on April 22, 2020 and 1/48th of the shares subject to the option continue to vest each month thereafter, provided that reporting person is a service provider to the issuer as of each such vesting date.